NDC 24571-103

PRISMASOL BGK2/3.5

Calcium Chloride, Magnesium Chloride, Dextrose Monohydrate, Lactic Acid, Sodium Chloride, Sodium Bicarbonate And Potassium Chloride

PRISMASOL BGK2/3.5 is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Calcium Chloride; Dextrose Monohydrate; Lactic Acid, Unspecified Form; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride.

Product ID24571-103_250f27ad-a700-4fd7-aaeb-7ca4211c17d8
NDC24571-103
Product TypeHuman Prescription Drug
Proprietary NamePRISMASOL BGK2/3.5
Generic NameCalcium Chloride, Magnesium Chloride, Dextrose Monohydrate, Lactic Acid, Sodium Chloride, Sodium Bicarbonate And Potassium Chloride
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2006-10-25
Marketing CategoryNDA / NDA
Application NumberNDA021703
Labeler NameBaxter Healthcare Corporation
Substance NameCALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Active Ingredient Strength5 g/L; g/L; g/L; g/L; g/L; g/L; g/L
Pharm ClassesAcidifying Activity [MoA], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 24571-103-06

2 BAG in 1 CASE (24571-103-06) > 5 L in 1 BAG
Marketing Start Date2006-10-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 24571-103-05 [24571010305]

PRISMASOL BGK2/3.5 INJECTION
Marketing CategoryNDA
Application NumberNDA021703
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2006-10-25
Marketing End Date2017-12-31

NDC 24571-103-06 [24571010306]

PRISMASOL BGK2/3.5 INJECTION
Marketing CategoryNDA
Application NumberNDA021703
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2006-10-25

Drug Details

Active Ingredients

IngredientStrength
CALCIUM CHLORIDE5.15 g/L

OpenFDA Data

SPL SET ID:7f675fee-8940-4ece-bb0c-75ac79d8708c
Manufacturer
UNII

Pharmacological Class

  • Blood Coagulation Factor [EPC]
  • Increased Coagulation Factor Activity [PE]
  • Calcium [CS]
  • Cations
  • Divalent [CS]
  • Calculi Dissolution Agent [EPC]
  • Magnesium Ion Exchange Activity [MoA]
  • Osmotic Laxative [EPC]
  • Osmotic Activity [MoA]
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
  • Increased Large Intestinal Motility [PE]
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
  • Osmotic Laxative [EPC]
  • Increased Large Intestinal Motility [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
  • Osmotic Activity [MoA]
  • Osmotic Laxative [EPC]
  • Increased Large Intestinal Motility [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
  • Osmotic Activity [MoA]
  • Potassium Compounds [CS]
  • Potassium Salt [EPC]
  • Osmotic Laxative [EPC]
  • Increased Large Intestinal Motility [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
  • Osmotic Activity [MoA]

NDC Crossover Matching brand name "PRISMASOL BGK2/3.5" or generic name "Calcium Chloride, Magnesium Chloride, Dextrose Monohydrate, Lactic Acid, Sodium Chloride, Sodium Bicarbonate And Potassium Chloride"

NDCBrand NameGeneric Name
24571-103PRISMASOLcalcium chloride, magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride
24571-105PRISMASOLcalcium chloride, magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride

Trademark Results [PRISMASOL]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PRISMASOL
PRISMASOL
78601301 3341085 Live/Registered
Gambro Lundia AB
2005-04-04
PRISMASOL
PRISMASOL
78032982 not registered Dead/Abandoned
Gambro, Inc.
2000-10-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.